Seoul
South Korea
12
2023-06-22
12
2024-02-20
These are the the leading inventors for applications assigned to KOBIOLABS, INC.:
KOBIOLABS, INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community
#2 | 2022-08-18 ✅ Patent 12,274,718 granted on 2025-04-15Composition and method for preventing, alleviating, or treating liver injury
#3 | 2022-06-09 ✅ Patent 11,819,526 granted on 2023-11-21Lactobacillus Gasseri KBL697 strain and use thereof
#4 | 2022-06-09 ✅ Patent 11,992,511 granted on 2024-05-28strain and use thereof
#5 | 2022-02-10 ✅ Patent 11,602,552 granted on 2023-03-14Lactobacillus plantarum KBL396 strain and use thereof
#6 | 2022-01-06 ✅ Patent 12,441,979 granted on 2025-10-14AKKERMANSIA MUCINIPHILA STRAIN AND USE THEREOF
#7 | 2022-01-06 ✅ Patent 11,633,439 granted on 2023-04-25Lactobacillus crispatus KBL693 strain and use thereof
#8 | 2021-04-01 ✅ Patent 11,285,183 granted on 2022-03-29KBL697 strain and use thereof
#9 | 2021-03-18 ✅ Patent 11,291,698 granted on 2022-04-05strain and use thereof
#10 | 2021-02-25 ✅ Patent 11,510,948 granted on 2022-11-29Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community
#11 | 2020-12-31 ✅ Patent 12,070,477 granted on 2024-08-27sp. strain having ability to inhibit growth of vaginal pathogenic microorganisms
#12 | 2019-08-29 ✅ Patent 11,365,452 granted on 2022-06-21Composition for diagnosing or predicting risk of metabolic syndrome or metabolic syndrome-related diseases using human oral microbiome
Also check out KoBioLabs, Inc.'s (Seoul, South Korea) applicant profile with 12 patent applications submitted.
347659 ⎘